1976
DOI: 10.1016/0035-9203(76)90178-4
|View full text |Cite
|
Sign up to set email alerts
|

Studies on the resistance of malaria to chloroquine and to a combination of chloroquine and pyrimethamine in Peninsular Malaysia

Abstract: In vivo chloroquine resistance surveys, which allowed for detection of late recrudescing RI resistance, were conducted in three regions of Peninsular Malaysia, which were previously not recognized as having appreciable drug resistance. Among the 485 Plasmodium falciparum infections tested resistance rates ranged locally from 20% to 67% in those with parasitaemias over 1,000 per mm3, and 5% to 59% in all parasitaemias. The region found to have the most serious resistance was western Pahang. In one study a combi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

1987
1987
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 5 publications
0
2
0
1
Order By: Relevance
“…In Malaysia, proguanil was deployed from the late 1940s, and resistance documented almost immediately. Pyrimethamine resistance was documented from the mid-1970s onwards[ 32 ], although sulfadoxine-pyrimethamine (SP) continued to be used as a first-line medication for the treatment and prophylaxis of P . falciparum for over 30 years until artemisinin-combination therapy (ACT) was introduced after 2009.…”
Section: Introductionmentioning
confidence: 99%
“…In Malaysia, proguanil was deployed from the late 1940s, and resistance documented almost immediately. Pyrimethamine resistance was documented from the mid-1970s onwards[ 32 ], although sulfadoxine-pyrimethamine (SP) continued to be used as a first-line medication for the treatment and prophylaxis of P . falciparum for over 30 years until artemisinin-combination therapy (ACT) was introduced after 2009.…”
Section: Introductionmentioning
confidence: 99%
“…However, the first case of chloroquine resistant (CQR) P. falciparum was reported in 1963 [ 5 ] and subsequently more CQR cases were reported from Sabah, Sarawak, and Peninsular Malaysia [ 4 , 6 , 7 ]. Therefore, sulphadoxine-pyrimethamine (SDX/PYR) was later adopted as the first-line treatment for uncomplicated falciparum malaria in Peninsular Malaysia and Sabah in 1979 [ 8 ]. And, to date, artemisinin-combinational therapy (ACTs) is used as the first-line treatment for uncomplicated falciparum malaria.…”
Section: Introductionmentioning
confidence: 99%
“…Sekali gus menukar komponen genetiknya menjadi lebih rintang. Laporan kerintangan ubat antimalaria (klorokuin) ke atas strain Plasmodium falciparum yang pertama di Malaysia dilaporkan pada tahun 1963 oleh Montgomery dan Eyles (1963), diikuti dengan beberapa laporan lain di Sabah (Clyde, Han & Huang 1973), gabungan klorokuinpirimetamin (Dondero Jr., Parsons & Ponnampalam 1976), sulfadoksin-pirimetamin dan akhir sekali keduadua gabungan di kawasan endemik Semenanjung Malaysia (Lokman et al 1996).…”
Section: Pengenalanunclassified